A three-day workshop equipped early-career Rockefeller researchers with skills rarely taught in graduate school, from managing laboratory operations to financial literacy and well-being.
A toolkit devised by Rockefeller scientists works toward reducing global health disparities by factoring access and affordability into the earliest stages of biomedical discovery.
Thirty years ago, an insight from a rare brain disease took Robert Darnell's career in an unexpected direction. He’s still surprised by what he’s learning.
Brief bursts of intense exercise trigger a molecular response linked to a lower risk of cardiovascular and metabolic disease and that are associated with slower biological aging.
New paper solves a longstanding mystery about how a class of antibiotics works and simultaneously reveals a key structural mechanism behind one of biology's most important enzymes.
In a new study, scientists uncover thousands of previously hidden genes and reveal ancient chromosome structures, with sweeping implications for the study of neuroscience and evolution.
Rockefeller's Birsoy and Vinogradova labs teamed up to study how cancer cells rewire their metabolism, and how these changes could be targeted therapeutically.
New study shows that arginine deficiency interferes with immune system gene expression, and increasing arginine intake in such instances could improve it.
Elizabeth Campbell studies the molecular machinery all living cells use to read and transcribe genetic instructions. Her lab finds new ways to block this critical machinery in bacteria and viruses.
FlatMux captures electrical activity optically from nearly 200 genetically defined neurons across brain circuits, revealing how signals flow, cells connect, and computations emerge in a living mouse brain.
As the Clinical Scholars Program marks a major milestone, alumni and leaders reflect on how physician-scientists have supported the university’s core mission, science for the benefit of humanity.
A newly discovered signaling network transmits advanced intelligence from distal regions of the body to the blood-brain barrier, giving the brain time to ready itself.
A new study suggests that caregiving behaviors are regulated by neural mechanisms that change over the course of an ant’s lifetime, a finding that offers insights into the origins of a crucial social behavior and how healthy brains age.
RockEDU’s long-running program gives New York City high school students access to authentic research experiences and a chance to envision themselves as scientists.
Paula Volent has elected to step back from her full-time role as vice president and CIO. Jun Yang will assume stewardship of the biomedical university's endowment starting July 1, 2026.
Book lovers made an unexpected connection at an Office for University Life and Community Engagement event. Now they have a club that gathers every month to read and discuss a work of sci-fi.
A new protein-tracing platform reveals how fat and liver cells communicate during fasting, inflammation, and obesity, and links many of those signals to human disease.
Joseph L. Goldstein received the David Rockefeller Award for Extraordinary Service and honorary degrees were bestowed upon Carolyn Bertozzi and Francis S. Collins.
Gabriel D. Victora's team has turned germinal centers into a living laboratory for one of biology's oldest questions: how much of evolution is shaped by chance?
A new study reveals how germinal centers produce powerful antibodies through noisy rounds of mutation and selection, offering new insight into vaccine design—and larger themes in evolution.
One of the most common drug resistance mutations in tuberculosis creates subtle metabolic weaknesses that could be exploited with future combination therapies.
President Lifton reflects on the university’s long history of innovation, why modern medicine would be unthinkable without basic science, and how the next wave of discoveries will shape the future.
The university’s Research Assistant Association, which holds its third annual poster session on May 20, is designed to build community and skills among its early-career scientists.
Svetlana Mojsov, whose research led to the development of revolutionary obesity drugs, has been promoted. She is now Rockefeller’s Lulu Chow Wang and Robin Chemers Neustein Research Professor.
The brain activity that occurs during the act of drawing reveals fundamental neural properties and has implications for the improvement of brain-computer interfaces and the study of brain disorders.
Two techniques—one for optics-free spatial mapping of tissue organization and the other for the enrichment of rare cell types—offer new ways to study aging and disease.
RNA polymerase, the enzyme that synthesizes RNA from DNA during transcription, has been captured mid-reaction for the first time. The findings provide a universal blueprint for gene expression.
The two scientists are the 35th and 36th members of Rockefeller's current faculty to be honored with membership in the prestigious academy founded by Abraham Lincoln.
The findings, which have implications for cancer and other diseases, resulted from capturing the first snapshot of a mechanical signaling complex in action.
By editing blood stem cells, researchers show that the immune system itself can be transformed into a durable, boostable source of therapeutic proteins—opening the door to novel treatments
Three years in, the Stavros Niarchos Foundation Institute for Global Infectious Disease Research has matured into a working pipeline connecting basic science and emerging therapies.
Researchers created the first mouse model in which chronic viral infection progresses to liver cancer, closely mirroring what happens in people with hepatitis C.
The Rockefeller teams will map immune cell interactions, engineer cells as drug delivery systems, and activate immune responses in hard-to-treat cancers.
Theodora Hatziioannou used her expertise on HIV-1 to gain insights into SARS-Co-V-2, and vice versa. The potential applications of her insights could be much broader.
The Rockefeller University Biotech Club is offering a series of talks, bringing in startup founders and industry experts to share their experience of turning lab discoveries into companies.
Researchers used a combination of wet lab research and deep machine learning to pinpoint distinct genetic sequences, work that could inform therapeutic strategies for chronic inflammation.
Long thought to serve as cellular scaffolding, microtubules also reshape the proteins that bind to them—guiding enzyme activity to prevent genetic errors linked to cancer.
